yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q35166825-4C6D0576-E449-459E-8041-F435FB9C4FEA
Q35166825-4C6D0576-E449-459E-8041-F435FB9C4FEA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35166825-4C6D0576-E449-459E-8041-F435FB9C4FEA
Rethinking clinical trials for cytostatic drugs.
P2860
Q35166825-4C6D0576-E449-459E-8041-F435FB9C4FEA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35166825-4C6D0576-E449-459E-8041-F435FB9C4FEA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2a6df9ae3ee7460ecb2913a7e3de2d2b6f27f28b
P2860
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group.